Aarti Drugs Q3 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
422.95
3.20 (0.76%)
3.20 (0.76%)Volume17.11 K
Updated: Fri 17 Jul, 2026 | 15:40:09
NSE
422.302.40 (0.57%)
2.40 (0.57%)Volume2.21 L
Updated: Fri 17 Jul, 2026 | 15:42:22
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Aarti Drugs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 564.62 | 545.01 | -3.45% | 508.67 | 11.00% |
| Depreciation/ Amortization | 17.95 | 13.72 | 10.39% | 13.80 | 30.07% |
| Operating Income | 37.09 | 53.32 | -45.47% | 47.93 | -22.62% |
| Net Income | 40.54 | 35.01 | -10.47% | 37.04 | 9.44% |
| Other Operating Expenses Total | 126.87 | 110.73 | -0.22% | 115.72 | 9.64% |
| Net Income Before Taxes | 29.02 | 45.88 | -51.96% | 50.76 | -42.83% |
| Total Revenue | 601.71 | 598.33 | -7.82% | 556.60 | 8.10% |
| Selling/ General/ Admin Expenses Total | 33.16 | 26.56 | 0.27% | 27.76 | 19.45% |
| Diluted Normalized EPS | 4.44 | 3.83 | -10.30% | 4.06 | 9.36% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.